mRNA/SOL
Puntuación | 28 |
|---|---|
Vol. en 24 h | 603,71 $ |
Liquidez | 2,1 mil $ |
Titulares | 90 |
Auditorías | |
Antigüedad | 3 días |
FDV | 2 mil $ |
Cap merc | 2 mil $ |
| Direcciones | |
|---|---|
| Pool | |
| mRNA | |
| SOL |  |
| Desarrollador |
Conversor de mRNA a SOL
Puntuación | 28 |
|---|---|
Vol. en 24 h | 603,71 $ |
Liquidez | 2,1 mil $ |
Titulares | 90 |
Auditorías | |
Antigüedad | 3 días |
FDV | 2 mil $ |
Cap merc | 2 mil $ |
Moderna Inc (mRNA)
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
Actualizar información del tokenEstadísticas de precio de mRNA/SOL
El precio actual de mRNA (mRNA/SOL) en PumpSwap is 0,00000201 $, lo que supone una subida de precio del -1,17 % en las últimas 24 horas. Se declara que su volumen de negociación en 24 horas es de 603,71 $ con un total de 13 transacciones. La dirección del contrato de mRNA/SOL es 8PuiDczBmQuTHtwK4YjtRsViQ74hE2jKZY4ib7wrfxN2, con una Valoración totalmente diluida (FDV) de 2010,19 $ y un pool de liquidez de 2086,00 $.
